We recently compiled a list of the 10 best investments during a recession. Cardinal Health, Inc. is one of the best investments on our list.
TheFly reported on January 9 that Citi upgraded CAH from Neutral to Buy, raising the price target from $190 to $244. Citi analyst Daniel Grosslight offered this upgrade, which shows confidence in the growth of the company’s specialty assets as well as the strong performance of its core pharmaceutical distribution business.
Citi highlighted further expansion of Cardinal Health, Inc.’s (NYSE:CAH) specialty business, especially the addition of recently acquired MSO assets such as Solaris Health, which is expected to improve operational efficiency and aid revenue growth. It was announced that the company remains cautious in the Global Medical Products and Distribution (GMPD) business, although it believes there is upside potential compared to its own expectations versus consensus forecasts.
Cardinal Health, Inc. (NYSE:CAH) is a large American healthcare products and services company headquartered in Dublin, Ohio. It distributes pharmaceutical products and medical supplies to hospitals, pharmacies and clinics around the world, and manufactures medical and surgical products. The business operates in two segments: pharmaceutical and specialty solutions and global medical products and distribution.
While we recognize CAH’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.
READ NEXT: The 12 Best Multibagger Stocks to Buy for 2026 and the 7 Best Rising Tech Stocks to Buy Now.
Disclosure: None.